Ethnicity
Diversity in clinical trials in Europe and the US: a review of a pharmaceutical company's data collection, reporting, and interpretation of race an...
Editorial
. 2023 Sep 27;S0923-7534(23)03945-5.
doi: 10.1016/j.annonc.2023.09.3107.
Online ahead of print.
...
Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility
Importance:
Using race and ethnicity in clinical prediction models can reduce or inadvertently increase racial and ethnic disparitie...
The interaction of mental health and race and ethnicity in juvenile justice placement decisions
Abstract
We investigated the interaction of mental health needs and race and ethnicity on juvenile justice placement decisions. Mental health diagn...
Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health–Funded Pediatric Clinical Trials | Equity, Diversit...
Key Points
Question
To what extent are participant race and ethnicity reported in publications and ClinicalTrials.gov, and how representa...
Toward Improving Race and Ethnicity Data in Health Care (RAISE)
In this episode, RDML Araojo speaks with Susan Winckler, Chief Executive Officer of the Reagan-Udall Foundation (RUF) for the FDA, and Carla Rodrig...
Study Finds Disparities in Home Health Care Linked to Race, Ethnicity and Income
MINNEAPOLIS, Minnesota—A study from the University of Minnesota (UMN) School of Public Health (SPH) quantified the degree to which home health care...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
